Chapter: 1: INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2: EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market Definition and Scope
3.2. IVF pricing trends
3.3. IVF Cycles by Country
3.4. Global IVF services market, by end user

3.4.1. Market size and forecast
3.4.2. Market volume and forecast
3.4.3. Fertility clinics

3.4.3.1. Market size and forecast

3.4.4. Hospitals

3.4.4.1. Market size and forecast

3.4.5. Surgical centers

3.4.5.1. Market size and forecast

3.4.6. Clinical research institutes

3.4.6.1. Market size and forecast

3.5. Global IVF services market by cycle type

3.5.1. Market size and forecast
3.5.2. Market volume and forecast
3.5.3. Fresh IVF cycles (non-donor)

3.5.3.1. Market size and forecast

3.5.4. Thawed IVF cycles (non-donor)

3.5.4.1. Market size and forecast

3.5.5. Donor egg IVF cycles

3.5.5.1. Market size and forecast

3.6. Market dynamics

3.6.1. Drivers

3.6.1.1. Delayed pregnancies in women
3.6.1.2. Increase in global infertility rates
3.6.1.3. Increase in gamete donations
3.6.1.4. Increase in disposable income
3.6.1.5. Increase in IVF success rates
3.6.1.6. Surge in healthcare expenditure worldwide

3.6.2. Restraints

3.6.2.1. Cost constraints
3.6.2.2. Complications associated with IVF treatment
3.6.2.3. Low awareness level

3.6.3. Opportunities

3.6.3.1. Fertility tourism
3.6.3.2. Growth opportunities in the emerging markets
3.6.3.3. Increase in number of fertility clinics
3.6.3.4. Rise in same sex marriage

3.6.4. Impact analyses

3.7. Key findings

Chapter: 4: NORTH AMERICA IVF SERVICES MARKET

4.1. Overview

4.1.1. Market size and forecast

4.1.1.1. By country
4.1.1.2. By End User
4.1.1.3. By Cycle Type

4.1.2. Market volume and forecast

4.1.2.1. By Country
4.1.2.2. By End User
4.1.2.3. By Cycle Type

4.2. U.S. IVF services market, (Revenue and Number of Cycles)

4.2.1. Overview
4.2.2. Market size and forecast
4.2.3. Fertility Clinics in U.S., 2016
4.2.4. U.S. IVF services market, by end user

4.2.4.1. Market size and forecast
4.2.4.2. Market volume and forecast
4.2.4.3. Fertility clinics
4.2.4.4. Hospitals
4.2.4.5. Surgical Centers
4.2.4.6. Clinical Research Institutes

4.2.5. U.S. IVF services market, by cycle type

4.2.5.1. Market size and forecast
4.2.5.2. Market volume and forecast
4.2.5.3. Fresh IVF cycles (non-donor)
4.2.5.4. Thawed IVF cycles (non-donor)
4.2.5.5. Donor egg IVF cycles

4.2.6. Market dynamics

4.2.6.1. Driving factors

4.2.6.1.1. Increasing popularity of IVF in U.S.
4.2.6.1.2. Increased rate of infertility and practices of embryo banking cycles

4.2.6.2. Restraining Factors

4.2.6.2.1. High cost of IVF treatment in U.S.
4.2.6.2.2. Restrictions on 3-parent IVF treatments
4.2.6.2.3. Scattered Reimbursements

4.2.7. Regulatory Issues, Legislations and Authorities
4.2.8. Insurance Reimbursement Scenario
4.2.9. Company Profiles

4.2.9.1. Fertility and Gynecology Center Monterey Bay IVF

4.2.9.1.1. Company overview

4.2.9.2. Conceptions Reproductive Associates of Colorado

4.2.9.2.1. Company overview

4.2.9.3. Servy Massey Fertility Institute

4.2.9.3.1. Company overview

4.2.9.4. Sher Institute for Reproductive Medicine (SIRM)

4.2.9.4.1. Company overview

4.2.9.5. Cardone Reproductive Medicine and Infertility, LLC

4.2.9.5.1. Company overview

4.2.9.6. Fertility Center of San Antoni

4.2.9.6.1. Company overview

4.2.9.7. Houston Fertility Center

4.2.9.7.1. Company overview

4.2.9.8. New hope fertility center

4.2.9.8.1. Company overview

4.3. Canada IVF services market, (Revenue and Number of Cycles)

4.3.1. Overview
4.3.2. Market size and forecast
4.3.3. IVF Clinics in Canada
4.3.4. Canada IVF services market, by end user

4.3.4.1. Market size and forecast
4.3.4.2. Market volume and forecast
4.3.4.3. Fertility clinics
4.3.4.4. Hospitals
4.3.4.5. Surgical Centers
4.3.4.6. Clinical Research Institutes

4.3.5. Canada IVF services market, by cycle type

4.3.5.1. Market size and forecast
4.3.5.2. Market volume and forecast
4.3.5.3. Fresh IVF cycles (non-donor)
4.3.5.4. Thawed IVF cycles (non-donor)
4.3.5.5. Donor egg IVF cycles

4.3.6. Market Dynamics

4.3.6.1. Driving Factors

4.3.6.1.1. Commercialization of IVF booster in Canada

4.3.6.2. Restraining Factors

4.3.6.2.1. High cost of IVF treatment in Canada

4.3.7. Regulatory Issues, Legislations and Authorities
4.3.8. Insurance Reimbursement Scenario
4.3.9. Company Profiles

4.3.9.1. TRIO Fertility

4.3.9.1.1. Company overview

4.3.9.2. The Montreal Fertility Center

4.3.9.2.1. Company overview

4.3.9.3. Procrea Fertility

4.3.9.3.1. Company overview

4.3.9.4. IVF Canada

4.3.9.4.1. Company overview

4.4. Mexico IVF services market, (Revenue and Number of Cycles)

4.4.1. Overview
4.4.2. Market size and forecast
4.4.3. Fertility Clinics in Mexico
4.4.4. Mexico IVF services market, by end user

4.4.4.1. Market size and forecast
4.4.4.2. Market volume and forecast
4.4.4.3. Fertility clinics
4.4.4.4. Hospitals
4.4.4.5. Surgical Centers
4.4.4.6. Clinical Research Institutes

4.4.5. Mexico IVF services market, by cycle type

4.4.5.1. Market size and forecast
4.4.5.2. Market volume and forecast
4.4.5.3. Fresh IVF cycles (non-donor)
4.4.5.4. Thawed IVF cycles (non-donor)
4.4.5.5. Donor egg IVF cycles

4.4.6. Market Dynamics

4.4.6.1. Driving Factors

4.4.6.1.1. Fertility tourism
4.4.6.1.2. Comparatively low cost of IVF

4.4.6.2. Restraining Factors

4.4.6.2.1. Language Barriers

4.4.7. Regulatory Issues, Legislations and Authorities
4.4.8. Insurance Reimbursement Scenario
4.4.9. Company Profiles

4.4.9.1. LIV Fertility Center

4.4.9.1.1. Company overview

4.4.9.2. Biofertility Center

4.4.9.2.1. Company overview

4.4.9.3. Ivinsemer

4.4.9.3.1. Company overview

Chapter: 5: EUROPE IVF SERVICES MARKET

5.1. Overview

5.1.1. Market size and forecast

5.1.1.1. By Country
5.1.1.2. By End User
5.1.1.3. By Cycle Type

5.1.2. Market volume and forecast

5.1.2.1. By Country
5.1.2.2. By End User
5.1.2.3. By Cycle Type

5.2. Germany IVF services market, (Revenue and Number of Cycles)

5.2.1. Overview
5.2.2. Market size and forecast
5.2.3. Fertility Clinics in Germany
5.2.4. Germany IVF services market, by end user

5.2.4.1. Market size and forecast
5.2.4.2. Market volume and forecast
5.2.4.3. Fertility clinics
5.2.4.4. Hospitals
5.2.4.5. Surgical Centers
5.2.4.6. Clinical Research Institutes

5.2.5. Germany IVF services market, by cycle type

5.2.5.1. Market size and forecast
5.2.5.2. Market volume and forecast
5.2.5.3. Fresh IVF cycles (non-donor)
5.2.5.4. Thawed IVF cycles (non-donor)

5.2.6. Market dynamics

5.2.6.1. Driving Factors

5.2.6.1.1. Subsidizing IVF treatments
5.2.6.1.2. Delayed marriages and parenthood decisions

5.2.6.2. Restraining Factors

5.2.6.2.1. Limited adoption of IVF methods

5.2.7. Regulatory Issues, Legislations and Authorities
5.2.8. Insurance Reimbursement Scenario
5.2.9. Company Profiles

5.2.9.1. Heidelberg University Hospital

5.2.9.1.1. Company overview

5.2.9.2. Wunschkinder

5.2.9.2.1. Company overview

5.2.9.3. Fertility Center Berlin

5.2.9.3.1. Company overview

5.2.9.4. amedes MVZ Cologne GmbH

5.2.9.4.1. Company overview

5.3. France IVF services market, (Revenue and Number of Cycles)

5.3.1. Overview
5.3.2. Market size and forecast
5.3.3. IVF Clinics in France
5.3.4. France IVF services market, by end user

5.3.4.1. Market size and forecast
5.3.4.2. Market volume and forecast
5.3.4.3. Fertility clinics
5.3.4.4. Hospitals
5.3.4.5. Surgical Centers
5.3.4.6. Clinical Research Institutes

5.3.5. France IVF services market, by cycle type

5.3.5.1. Market size and forecast
5.3.5.2. Market volume and forecast
5.3.5.3. Fresh IVF cycles (non-donor)
5.3.5.4. Thawed IVF cycles (non-donor)
5.3.5.5. Donor egg IVF cycles

5.3.6. Market Dynamics

5.3.6.1. Driving Factors

5.3.6.1.1. Rising adoption of IVF babies among same gender population
5.3.6.1.2. Lower rates of Fertility

5.3.6.2. Restraining Factors

5.3.6.2.1. Stringent government regulations

5.3.7. Regulatory Issues, Legislations and Authorities
5.3.8. Insurance Reimbursement Scenario
5.3.9. Company Profiles

5.3.9.1. Ambroise Par Group

5.3.9.1.1. Company overview

5.3.9.2. AMP Center St Roch

5.3.9.2.1. Company overview

5.4. UK IVF services market, (Revenue and Number of Cycles)

5.4.1. Overview
5.4.2. Market size and forecast
5.4.3. Fertility Clinics in UK
5.4.4. UK IVF services market, by end user

5.4.4.1. Market size and forecast
5.4.4.2. Market volume and forecast
5.4.4.3. Fertility clinics
5.4.4.4. Hospitals
5.4.4.5. Surgical Centers
5.4.4.6. Clinical Research Institutes

5.4.5. UK IVF services market, by cycle type

5.4.5.1. Market size and forecast
5.4.5.2. Market volume and forecast
5.4.5.3. Fresh IVF cycles (non-donor)
5.4.5.4. Thawed IVF cycles (non-donor)
5.4.5.5. Donor egg IVF cycles

5.4.6. Market Dynamics

5.4.6.1. Driving Factors

5.4.6.1.1. Commercialization of three-parent IVF procedures
5.4.6.1.2. Supportive Regulations

5.4.6.2. Restraining Factors

5.4.6.2.1. Ethical considerations

5.4.7. Regulatory Issues, Legislations and Authorities
5.4.8. Insurance Reimbursement Scenario
5.4.9. Company Profiles

5.4.9.1. The Lister Fertility Clinic

5.4.9.1.1. Company overview

5.4.9.2. The Bridge Centre

5.4.9.2.1. Company overview

5.4.9.3. Chelsea and Westminster Hospital (Assisted Conception Unit)

5.4.9.3.1. Company overview

5.5. Italy IVF services market, (Revenue and Number of Cycles)

5.5.1. Overview
5.5.2. Market size and forecast
5.5.3. Italy IVF services market, by end user

5.5.3.1. Market size and forecast
5.5.3.2. Market volume and forecast
5.5.3.3. Fertility clinics
5.5.3.4. Hospitals
5.5.3.5. Surgical Centers
5.5.3.6. Clinical Research Institutes

5.5.4. Italy IVF services market, by cycle type

5.5.4.1. Market size and forecast
5.5.4.2. Market volume and forecast
5.5.4.3. Fresh IVF cycles (non-donor)
5.5.4.4. Thawed IVF cycles (non-donor)
5.5.4.5. Donor egg IVF cycles

5.5.5. Market Dynamics

5.5.5.1. Driving Factors

5.5.5.1.1. Rise in medical tourism

5.5.5.2. Restraining Factors

5.5.5.2.1. Ban on Surrogacy

5.5.6. Regulatory Issues, Legislations and Authorities
5.5.7. Insurance Reimbursement Scenario
5.5.8. Company Profiles

5.5.8.1. The ARC-STER Center

5.5.8.1.1. Company overview

5.5.8.2. RAPRUI Srl

5.5.8.2.1. Company overview

5.5.8.3. Fivet Centers Prof. Zech

5.5.8.3.1. Company overview

5.6. Spain IVF services market, (Revenue and Number of Cycles)

5.6.1. Overview
5.6.2. Market size and forecast
5.6.3. Spain IVF services market, by end user

5.6.3.1. Market size and forecast
5.6.3.2. Market volume and forecast
5.6.3.3. Fertility clinics
5.6.3.4. Hospitals
5.6.3.5. Surgical Centers
5.6.3.6. Clinical Research Institutes

5.6.4. Spain IVF services market, by cycle type

5.6.4.1. Market size and forecast
5.6.4.2. Market volume and forecast
5.6.4.3. Fresh IVF cycles (non-donor)
5.6.4.4. Thawed IVF cycles (non-donor)
5.6.4.5. Donor egg IVF cycles

5.6.5. Market Dynamics

5.6.5.1. Driving Factors

5.6.5.1.1. Increase in the number of foreign patients

5.6.5.2. Restraining Factors

5.6.5.2.1. Limited awareness and language barriers

5.6.6. Regulatory Issues, Legislations and Authorities
5.6.7. Insurance Reimbursement Scenario
5.6.8. Company Profiles

5.6.8.1. IVF Spain

5.6.8.1.1. Company overview

5.6.8.2. EUVITRO S.L.U.

5.6.8.2.1. Company overview

5.6.8.3. FIV Marbella

5.6.8.3.1. Company overview

5.7. Denmark IVF services market, (Revenue and Number of Cycles)

5.7.1. Overview
5.7.2. Market size and forecast
5.7.3. Denmark IVF services market, by end user

5.7.3.1. Market size and forecast
5.7.3.2. Market volume and forecast
5.7.3.3. Fertility clinics
5.7.3.4. Hospitals
5.7.3.5. Surgical Centers
5.7.3.6. Clinical Research Institutes

5.7.4. Denmark IVF services market, by cycle type

5.7.4.1. Market size and forecast
5.7.4.2. Market volume and forecast
5.7.4.3. Fresh IVF cycles (non-donor)
5.7.4.4. Thawed IVF cycles (non-donor)
5.7.4.5. Donor egg IVF cycles

5.7.5. Market Dynamics

5.7.5.1. Driving Factors

5.7.5.1.1. Increase in disposable income
5.7.5.1.2. Advances in IVF technology

5.7.5.2. Restraining Factors

5.7.5.2.1. Reimbursement in public clinics only

5.7.6. Regulatory Issues, Legislations and Authorities
5.7.7. Insurance Reimbursement Scenario
5.7.8. Company Profiles

5.7.8.1. Vitanova

5.7.8.1.1. Company overview

5.7.8.2. Dansk Fertilitetsklinik

5.7.8.2.1. Company overview

5.7.8.3. StorkKlinik (Stork IVF Clinic)

5.7.8.3.1. Company overview

5.7.8.4. Trianglen Fertility Clinic

5.7.8.4.1. Company overview

5.8. Russia IVF services market, (Revenue and Number of Cycles)

5.8.1. Overview
5.8.2. Market size and forecast
5.8.3. Russia IVF services market, by end user

5.8.3.1. Market size and forecast
5.8.3.2. Market volume and forecast
5.8.3.3. Fertility clinics
5.8.3.4. Hospitals
5.8.3.5. Surgical Centers
5.8.3.6. Clinical Research Institutes

5.8.4. Russia IVF services market, by cycle type

5.8.4.1. Market size and forecast
5.8.4.2. Market volume and forecast
5.8.4.3. Fresh IVF cycles (non-donor)
5.8.4.4. Thawed IVF cycles (non-donor)
5.8.4.5. Donor egg IVF cycles

5.8.5. Market Dynamics

5.8.5.1. Driving Factors

5.8.5.1.1. Rising popularity of fertility tourism

5.8.5.2. Restraining Factors

5.8.5.2.1. Language barrier

5.8.6. Regulatory Issues, Legislations and Authorities
5.8.7. Insurance Reimbursement Scenario
5.8.8. Company Profiles

5.8.8.1. AVA Clinic Scanfert

5.8.8.1.1. Company overview

5.8.8.2. MD Medical Group

5.8.8.2.1. Company overview

5.8.8.3. International Centre for Reproductive Medicine, ICRM

5.8.8.3.1. Company overview

5.9. Rest of Europe IVF services market, (Revenue and Number of Cycles)

5.9.1. Overview
5.9.2. Market size and forecast
5.9.3. Rest of Europe IVF services market, by end user

5.9.3.1. Market size and forecast
5.9.3.2. Market volume and forecast
5.9.3.3. Fertility clinics
5.9.3.4. Hospitals
5.9.3.5. Surgical Centers
5.9.3.6. Clinical Research Institutes

5.9.4. Rest of Europe IVF services market, by cycle type

5.9.4.1. Market size and forecast
5.9.4.2. Market volume and forecast
5.9.4.3. Fresh IVF cycles (non-donor)
5.9.4.4. Thawed IVF cycles (non-donor)
5.9.4.5. Donor egg IVF cycles

5.9.5. Market Dynamics

5.9.5.1. Driving Factors

5.9.5.1.1. Wide availability of reimbursements
5.9.5.1.2. Changes in Lifestyle

5.9.5.2. Restraining Factors

5.9.6. Regulatory Issues, Legislations and Authorities
5.9.7. Insurance Reimbursement Scenario
5.9.8. Company Profiles

5.9.8.1. Betamedics

5.9.8.1.1. Company overview

5.9.8.2. OVA IVF Clinic Zurich

5.9.8.2.1. Company overview

5.9.8.3. VivaNeo - Medical Center Kinderwens

5.9.8.3.1. Company overview

Chapter: 6: ASIA- PACIFIC IVF SERVICES MARKET

6.1. Overview

6.1.1. Market size and forecast

6.1.1.1. By Country
6.1.1.2. By End User
6.1.1.3. By Cycle Type

6.1.2. Market volume and forecast

6.1.2.1. By Country
6.1.2.2. By End User
6.1.2.3. By Cycle Type

6.2. India IVF Services Market, (Revenue and Number of Cycles)

6.2.1. Overview
6.2.2. Market size and forecast
6.2.3. Fertility center in India, 2017
6.2.4. India IVF Services Market, by end user

6.2.4.1. Market size and forecast
6.2.4.2. Market volume and forecast
6.2.4.3. Fertility clinics
6.2.4.4. Hospitals
6.2.4.5. Surgical Centers
6.2.4.6. Clinical research institutes

6.2.5. India IVF services market, by cycle type

6.2.5.1. Market size and forecast
6.2.5.2. Market volume and forecast
6.2.5.3. Fresh IVF cycles (non-donor)
6.2.5.4. Thawed IVF cycles (non-donor)
6.2.5.5. Donor egg IVF cycles

6.2.6. Market Dynamics

6.2.6.1. Driving Factors
6.2.6.2. Restraining Factors

6.2.7. Regulatory issues, legislations and authorities
6.2.8. Insurance reimbursement scenario
6.2.9. Company profile

6.2.9.1. Bourn Hall Fertility Center

6.2.9.1.1. Company overview

6.2.9.2. Southend Fertility and IVF

6.2.9.2.1. Company overview

6.2.9.3. Morpheus Life Sciences Pvt. Ltd.

6.2.9.3.1. Company overview

6.2.9.4. Bloom Fertility Center

6.2.9.4.1. Company overview

6.2.9.5. Bloom Fertility and Healthcare

6.2.9.5.1. Company overview

6.2.9.6. Manipal Fertility

6.2.9.6.1. Company overview

6.2.9.7. Cloudnine Fertility

6.2.9.7.1. Company overview

6.3. China IVF Services Market, (Revenue and Number of Cycles)

6.3.1. Overview
6.3.2. Market size and forecast
6.3.3. China IVF Services Market, by end user

6.3.3.1. Market size and forecast
6.3.3.2. Market volume and forecast
6.3.3.3. Fertility clinics
6.3.3.4. Hospitals
6.3.3.5. Surgical Centers
6.3.3.6. Clinical research institutes

6.3.4. China IVF services market, by cycle type

6.3.4.1. Market size and forecast
6.3.4.2. Market volume and forecast
6.3.4.3. Fresh IVF cycles (non-donor)
6.3.4.4. Thawed IVF cycles (non-donor)
6.3.4.5. Donor egg IVF cycles

6.3.5. Market Dynamics

6.3.5.1. Driving Factors
6.3.5.2. Restraining Factors

6.3.6. Regulatory issues, legislations and authorities
6.3.7. Insurance reimbursement scenario
6.3.8. Company profile

6.3.8.1. Shanghai Ji Ai Genetics & IVF Institute

6.3.8.1.1. Company overview

6.3.8.2. Shanghai United Family Hospital

6.3.8.2.1. Company overview

6.4. Japan IVF Services Market, (Revenue and Number of Cycles)

6.4.1. Overview
6.4.2. Market size and forecast
6.4.3. Japan IVF services Market, by end user

6.4.3.1. Market size and forecast
6.4.3.2. Market volume and forecast
6.4.3.3. Fertility clinics
6.4.3.4. Hospitals
6.4.3.5. Surgical Centers
6.4.3.6. Clinical research institutes

6.4.4. Japan IVF services market, by cycle type

6.4.4.1. Market size and forecast
6.4.4.2. Market volume and forecast
6.4.4.3. Fresh IVF cycles (non-donor)
6.4.4.4. Thawed IVF cycles (non-donor)
6.4.4.5. Donor egg IVF cycles

6.4.5. Market Dynamics

6.4.5.1. Driving Factors
6.4.5.2. Restraining Factors

6.4.6. Regulatory issues, legislations and authorities
6.4.7. Insurance reimbursement scenario
6.4.8. Company profile

6.4.8.1. IVF NAMBA Clinic

6.4.8.1.1. Company overview

6.4.8.2. Sanno Hospital

6.4.8.2.1. Company overview

6.4.8.3. Oak Medical Group/Oak Clinic

6.4.8.3.1. Company overview

6.5. Australia IVF Services Market, (Revenue and Number of Cycles)

6.5.1. Overview
6.5.2. Market size and forecast
6.5.3. Fertility center in Australia, 2017
6.5.4. Australia IVF Services Market, by end user

6.5.4.1. Market size and forecast
6.5.4.2. Market volume and forecast
6.5.4.3. Fertility clinics
6.5.4.4. Hospitals
6.5.4.5. Surgical Centers
6.5.4.6. Clinical research institutes

6.5.5. Australia IVF services market, by cycle type

6.5.5.1. Market size and forecast
6.5.5.2. Market volume and forecast
6.5.5.3. Fresh IVF cycles (non-donor)
6.5.5.4. Thawed IVF cycles (non-donor)
6.5.5.5. Donor egg IVF cycles

6.5.6. Market Dynamics

6.5.6.1. Driving Factors
6.5.6.2. Restraining Factors

6.5.7. Regulatory issues, legislations and authorities
6.5.8. Insurance reimbursement scenario
6.5.9. Company profile

6.5.9.1. Virtus Health

6.5.9.1.1. Company overview

6.5.9.2. Monash IVF Wesley Hospital Auchenflower

6.5.9.2.1. Company overview

6.5.9.3. Fertility First

6.5.9.3.1. Company overview

6.5.9.4. Flinders Reproductive Medicine Pty Ltd

6.5.9.4.1. Company overview

6.6. New Zealand IVF Services Market, (Revenue and Number of Cycles)

6.6.1. Overview
6.6.2. Market size and forecast
6.6.3. New Zealand IVF Services Market, by end user

6.6.3.1. Market size and forecast
6.6.3.2. Market volume and forecast
6.6.3.3. Fertility clinics
6.6.3.4. Hospitals
6.6.3.5. Surgical Centers
6.6.3.6. Clinical research institutes

6.6.4. New Zealand IVF services market, by cycle type

6.6.4.1. Market size and forecast
6.6.4.2. Market volume and forecast
6.6.4.3. Fresh IVF cycles (non-donor)
6.6.4.4. Thawed IVF cycles (non-donor)
6.6.4.5. Donor egg IVF cycles

6.6.5. Market Dynamics

6.6.5.1. Driving Factors
6.6.5.2. Restraining Factors

6.6.6. Regulatory issues, legislations and authorities
6.6.7. Insurance reimbursement scenario
6.6.8. Company profile

6.6.8.1. Fertility Associates

6.6.8.1.1. Company overview

6.6.8.2. Genea Oxford Fertility Limited

6.6.8.2.1. Company overview

6.6.8.3. Repromed

6.6.8.3.1. Company overview

6.7. South Korea IVF Services Market, (Revenue and Number of Cycles)

6.7.1. Overview
6.7.2. Market size and forecast
6.7.3. Fertility center in South Korea, 2017
6.7.4. South Korea IVF Services Market, by end user

6.7.4.1. Market size and forecast
6.7.4.2. Market volume and forecast
6.7.4.3. Fertility clinics
6.7.4.4. Hospitals
6.7.4.5. Surgical Centers
6.7.4.6. Clinical research institutes

6.7.5. South Korea IVF services market, by cycle type

6.7.5.1. Market size and forecast
6.7.5.2. Market volume and forecast
6.7.5.3. Fresh IVF cycles (non-donor)
6.7.5.4. Thawed IVF cycles (non-donor)
6.7.5.5. Donor egg IVF cycles

6.7.6. Market Dynamics

6.7.6.1. Driving Factors
6.7.6.2. Restraining Factors

6.7.7. Regulatory issues, legislations and authorities
6.7.8. Insurance reimbursement scenario
6.7.9. Company profile

6.7.9.1. CHA Fertility Center

6.7.9.1.1. Company overview

6.7.9.2. Maria Fertility Hospital

6.7.9.2.1. Company overview

6.8. Thailand IVF Services Market, (Revenue and Number of Cycles)

6.8.1. Overview
6.8.2. Market size and forecast
6.8.3. Thailand IVF Services Market, by end user

6.8.3.1. Market size and forecast
6.8.3.2. Market volume and forecast
6.8.3.3. Fertility clinics
6.8.3.4. Hospitals
6.8.3.5. Surgical Centers
6.8.3.6. Clinical research institutes

6.8.4. Thailand IVF services market, by cycle type

6.8.4.1. Market size and forecast
6.8.4.2. Market volume and forecast
6.8.4.3. Fresh IVF cycles (non-donor)
6.8.4.4. Thawed IVF cycles (non-donor)
6.8.4.5. Donor egg IVF cycles

6.8.5. Market Dynamics

6.8.5.1. Driving Factors
6.8.5.2. Restraining Factors

6.8.6. Regulatory issues, legislations and authorities
6.8.7. Insurance reimbursement scenario
6.8.8. Company profile

6.8.8.1. SAFE Fertility Center

6.8.8.1.1. Company overview

6.8.8.2. Bangkok IVF center (Bangkok Hospital)

6.8.8.2.1. Company overview

6.8.8.3. Bangkok IVF center

6.8.8.3.1. Company overview

6.9. Rest of Asia-Pacific IVF Services Market, (Revenue and Number of Cycles)

6.9.1. Overview
6.9.2. Market size and forecast
6.9.3. Rest of Asia-Pacific IVF Services Market, by end user

6.9.3.1. Market size and forecast
6.9.3.2. Market volume and forecast
6.9.3.3. Fertility clinics
6.9.3.4. Hospitals
6.9.3.5. Surgical Centers
6.9.3.6. Clinical research institutes

6.9.4. Rest of Asia-Pacific IVF services market, by cycle type

6.9.4.1. Market size and forecast
6.9.4.2. Market volume and forecast
6.9.4.3. Fresh IVF cycles (non-donor)
6.9.4.4. Thawed IVF cycles (non-donor)
6.9.4.5. Donor egg IVF cycles

6.9.5. Market Dynamics

6.9.5.1. Driving Factors
6.9.5.2. Restraining Factors

6.9.6. Regulatory issues, legislations and authorities
6.9.7. Insurance reimbursement scenario
6.9.8. Company profile

6.9.8.1. Center for Advanced Reproductive Medicine and Infertility

6.9.8.1.1. Company overview

6.9.8.2. Thomson Medical Pte. Ltd.

6.9.8.2.1. Company overview

6.9.8.3. KL Fertility & Gynaecology Centre

6.9.8.3.1. Company overview

Chapter: 7: LAMEA IVF SERVICES MARKET

7.1. Overview

7.1.1. Market size and forecast

7.1.1.1. By Country
7.1.1.2. By End User
7.1.1.3. By Cycle Type

7.1.2. Market volume and forecast

7.1.2.1. By Country
7.1.2.2. By End User
7.1.2.3. By Cycle Type

7.2. Latin America IVF Services Market, (Revenue and Number of Cycles)

7.2.1. Overview
7.2.2. Market size and forecast
7.2.3. Fertility center in Latin America, 2017
7.2.4. Latin America IVF Services Market, by end user

7.2.4.1. Market size and forecast
7.2.4.2. Market volume and forecast
7.2.4.3. Fertility clinics
7.2.4.4. Hospitals
7.2.4.5. Surgical Centers
7.2.4.6. Clinical research institutes

7.2.5. Latin America IVF services market, by cycle type

7.2.5.1. Market size and forecast
7.2.5.2. Market volume and forecast
7.2.5.3. Fresh IVF cycles (non-donor)
7.2.5.4. Thawed IVF cycles (non-donor)
7.2.5.5. Donor egg IVF cycles

7.2.6. Market Dynamics

7.2.6.1. Driving Factors
7.2.6.2. Restraining Factors

7.2.7. Regulatory issues, legislations and authorities
7.2.8. Insurance reimbursement scenario
7.2.9. Company profile

7.2.9.1. IVI Panama

7.2.9.1.1. Company overview

7.2.9.2. IVF Panama Center for Reproduction Punta Pacfica

7.2.9.2.1. Company overview

7.2.9.3. The Hugh Wynter Fertility Management Unit

7.2.9.3.1. Company overview

7.3. Middle East IVF Services Market, (Revenue and Number of Cycles)

7.3.1. Overview
7.3.2. Market size and forecast
7.3.3. Fertility center in Middle East, 2017
7.3.4. Middle East IVF Services Market, by end user

7.3.4.1. Market size and forecast
7.3.4.2. Market volume and forecast
7.3.4.3. Fertility clinics
7.3.4.4. Hospitals
7.3.4.5. Surgical Centers
7.3.4.6. Clinical research institutes

7.3.5. Middle East IVF services market, by cycle type

7.3.5.1. Market size and forecast
7.3.5.2. Market volume and forecast
7.3.5.3. Fresh IVF cycles (non-donor)
7.3.5.4. Thawed IVF cycles (non-donor)
7.3.5.5. Donor egg IVF cycles

7.3.6. Market Dynamics

7.3.6.1. Driving Factors
7.3.6.2. Restraining Factors

7.3.7. Regulatory issues, legislations and authorities
7.3.8. Insurance reimbursement scenario
7.3.9. Company profile

7.3.9.1. Cyprus IVF Centre

7.3.9.1.1. Company overview

7.3.9.2. Bourn Hall International

7.3.9.2.1. Company overview

7.3.9.3. Fakih IVF Fertility Center

7.3.9.3.1. Company overview

7.4. Africa IVF Services Market, (Revenue and Number of Cycles)

7.4.1. Overview
7.4.2. Market size and forecast
7.4.3. Fertility center in Africa, 2016
7.4.4. Africa IVF Services Market, by end user

7.4.4.1. Market size and forecast
7.4.4.2. Market volume and forecast
7.4.4.3. Fertility clinics
7.4.4.4. Hospitals
7.4.4.5. Surgical Centers
7.4.4.6. Clinical research institutes

7.4.5. Africa IVF services market, by cycle type

7.4.5.1. Market size and forecast
7.4.5.2. Market volume and forecast
7.4.5.3. Fresh IVF cycles (non-donor)
7.4.5.4. Thawed IVF cycles (non-donor)
7.4.5.5. Donor egg IVF cycles

7.4.6. Market Dynamics

7.4.6.1. Driving Factors
7.4.6.2. Restraining Factors

7.4.7. Regulatory issues, legislations and authorities
7.4.8. Insurance reimbursement scenario
7.4.9. Company profile

7.4.9.1. Medfem Fertility Clinic

7.4.9.1.1. Company overview

7.4.9.2. The Cape Fertility Clinic

7.4.9.2.1. Company overview

7.4.9.3. Lifesure Fertility and Gynaecology centre

7.4.9.3.1. Company overview